← Issue №8/ week of Aug 23, 2026/Pancreas/Biliary

Timing of cholecystectomy after acute biliary pancreatitis: Impact of disease severity and biological sex.

From GI Signals issue №8: what this paper found, what it changes, and where it sits against the current standard of care, reviewed by Simon Mathews, MD.

Pancreas/Biliary retrospective · n=205 · Aug 18, 2026 · Dig Liver Dis · IF 4.2

Timing of cholecystectomy after acute biliary pancreatitis: Impact of disease severity and biological sex.

New evidenceacute pancreatitishealth services
Clinical takeawayFor mild biliary pancreatitis, early cholecystectomy during index admission remains safe; counsel male patients about anticipated surgical complexity and intensive care utilization. For moderate/severe biliary pancreatitis, particularly in female patients, consider interval cholecystectomy to reduce intensive care duration and hospitalization length. Use disease severity and sex to individualize timing strategies and set realistic expectations for recovery resource needs.
What it foundOverall postoperative morbidity did not differ between early one-stage and interval cholecystectomy after biliary pancreatitis, but one-stage surgery increased postoperative inflammatory response, intensive care need, and hospitalization duration. In males with mild disease, surgery was more complex with longer operative times and higher conversion rates. In females with moderate/severe disease, one-stage surgery resulted in prolonged intensive care and trend toward prolonged hospitalization.
ContextCurrent practice recommends early cholecystectomy within the index admission for mild acute biliary pancreatitis and interval surgery for moderate/severe disease. This study confirms early surgery is morbidity-safe in mild disease but refines the approach by identifying sex-specific patterns in resource utilization and operative complexity. The findings support individualization by severity and sex rather than applying uniform timing strategies.
Refinessuggested applicable standard· American College of Gastroenterology, "American College of Gastroenterology Guidelines: Management of Acute Pancreatitis" (Tenner S, Vege SS, Sheth SG, et al.), Am J Gastroenterol 2024;119(3):419-437

Decision at staketiming of cholecystectomy after acute biliary pancreatitis, stratified by disease severity

Perform cholecystectomy preferably before discharge for mild acute biliary pancreatitis, and after a second unexplained AP episode even without identified gallstones; reserve ERCP within 24h for AP complicated by cholangitis, with rectal indomethacin +/- pancreatic duct stent and periprocedural hydration to reduce post-ERCP pancreatitis risk.

From our summary of this standard, unedited — the part the paper bears on. marks omitted text. Our wording, not the guideline's; read the source for its own text.

Our full summary of this standard

Diagnose acute pancreatitis (AP) by the Atlanta criteria (2 of 3: characteristic epigastric/LUQ pain, lipase or amylase >3x ULN [lipase preferred for specificity/duration], or characteristic imaging). ACG 2024 stratifies severity risk using SIRS on admission plus bedside risk factors, rising/elevated BUN, rising/elevated hematocrit (>44), obesity (BMI>30), extrapancreatic fluid collections/pleural effusion/infiltrates, altered mental status, and older age/comorbidities, rather than mandating a formal BISAP or APACHE II composite score. Give moderately aggressive lactated Ringer's, most important in the first 6-12 hours, reassessing volume status/BUN/HCT at 6 hours (further aggressive hydration has little added benefit after 24-48h). Start oral low-fat solid food within 24-48h as tolerated in mild disease; if enteral feeding is needed for moderately severe/severe disease, prefer nasogastric over nasojejunal with small-peptide/medium-chain-triglyceride formula and continuous (not bolus/cyclic) feeding; avoid parenteral nutrition if possible. Do not give prophylactic antibiotics, even in severe disease or sterile necrosis; reserve antibiotics for suspected infected necrosis (typically arising 10-14 days in), and choose agents that penetrate pancreatic necrosis while together covering both gut-derived gram-negative enterics and anaerobes, a carbapenem supplies this as monotherapy, whereas a fluoroquinolone or a third-or-higher-generation cephalosporin must be combined with metronidazole; metronidazole alone (anaerobic cover only), or a cephalosporin or a quinolone alone, does not adequately treat infected necrosis. Perform cholecystectomy preferably before discharge for mild acute biliary pancreatitis, and after a second unexplained AP episode even without identified gallstones; reserve ERCP within 24h for AP complicated by cholangitis, with rectal indomethacin +/- pancreatic duct stent and periprocedural hydration to reduce post-ERCP pancreatitis risk. Check triglycerides when gallstones/alcohol are absent (>1000 mg/dL supports a hypertriglyceridemia etiology). For stable pancreatic necrosis, defer surgical, radiological, or endoscopic intervention 4-6 weeks to allow walling-off (step-up approach).

American College of Gastroenterology, "American College of Gastroenterology Guidelines: Management of Acute Pancreatitis" (Tenner S, Vege SS, Sheth SG, et al.), Am J Gastroenterol 2024;119(3):419-437 · reviewed 2026-07-20 ↗
Bender F … Reichert M · Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver · IF 4.2 · PubMed ↗Permalink
← Read the whole of issue №8 Every paper GI Signals surfaces gets a page like this one. All issues